Lessons on Telemedicine in Rheumatology: Thinking beyond the Coronavirus Disease 2019 Pandemic.

Area of Science:

• Rheumatology
• Digital Health
• Healthcare Policy

Background:

• The COVID-19 pandemic necessitated rapid telemedicine adoption in rheumatology.
• Limited evidence initially guided telemedicine appropriateness for rheumatology outpatient encounters.
• Regulatory changes, including waivers and reimbursement adjustments, facilitated telemedicine provision.

Purpose of the Study:

• To analyze the evolution and impact of telemedicine in rheumatology during the pandemic.
• To identify factors influencing the appropriateness of telemedicine for rheumatic disease patients.
• To explore future potential and persistent barriers to telemedicine integration in rheumatology.

Main Methods:

• Review of telemedicine deployment and practice pattern evolution in rheumatology.
• Analysis of research trends in telemedicine appropriateness for rheumatic diseases.
• Identification of regulatory and reimbursement factors enabling virtual care.

Main Results:

• Telemedicine research in rheumatology grew significantly, revealing factors for its appropriate use.
• Rheumatology practices adapted by incorporating patient-reported outcomes and modified physical exams.
• Regulatory waivers and increased reimbursement were crucial for sustained telemedicine services.

Conclusions:

• Telemedicine offers potential to enhance access to rheumatology care through efficient resource utilization.
• Barriers such as workforce training, reimbursement, and legal variability hinder full integration.
• A patient-centered approach is essential for safe, effective, and equitable future rheumatology telemedicine.